Key result
Myocardial ischemia may play an important role in the development and prognosis of dilated cardiomyopathy, suggesting a potential benefit for anti-ischemic therapy.
Myocardial ischemia and microvascular dysfunction may play a significant pathophysiological and prognostic role in dilated cardiomyopathy, representing a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Myocardial ischemia may contribute to DCM progression; leaves open whether perfusion-targeted strategies improve outcomes.
Fang et al. (2010) conducted a review in Dilated cardiomyopathy. Myocardial ischemia was evaluated. Myocardial ischemia may play an important role in the development and prognosis of dilated cardiomyopathy, suggesting a potential benefit for anti-ischemic therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: